{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T08:10:20Z","timestamp":1684051820217},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,9,29]],"date-time":"2007-09-29T00:00:00Z","timestamp":1191024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s00108-007-1933-7","type":"journal-article","created":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T19:39:19Z","timestamp":1190921959000},"page":"1297-1304","source":"Crossref","is-referenced-by-count":1,"title":["Immunglobuline bei Antik\u00f6rpermangelsyndrom","Immunoglobulins in primary antibody deficiency"],"prefix":"10.1007","volume":"48","author":[{"given":"S.","family":"Kluge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"de Heer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nierhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kreymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,29]]},"reference":[{"key":"1933_CR1","unstructured":"Alejandria MM, Lansang MA, Dans LF, Mantaring JB (2002) Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev CD001090"},{"key":"1933_CR2","first-page":"273","volume":"12","author":"Bass","year":"1993","unstructured":"Bass EB, Powe NR, Goodman SN et al. (1993) Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis. Bone Marrow Transplant 12: 273\u2013282","journal-title":"Bone Marrow Transplant"},{"key":"1933_CR3","doi-asserted-by":"crossref","unstructured":"Berger D, Schleich S, Seidelmann M, Beger H (1993) Antiendotoxic therapy with polyclonal and polyvalent immunoglobulins: in vitro and in vivo studies. In: Faist E, Meakins J, Schildberg FW (eds) Host defense dysfunction in trauma, shock and sepsis. Springer, Berlin Heidelberg New York, pp\u00a01163\u20131174","DOI":"10.1007\/978-3-642-77405-8_151"},{"key":"1933_CR4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-2004-820297","volume":"217","author":"Borte","year":"2005","unstructured":"Borte M, Oertelt C, Hogy B (2005) Behandlung von Patienten mit prim\u00e4ren Antik\u00f6rpermangelsyndromen in Deutschland. Klin Padiatr 217: 276\u2013280","journal-title":"Klin Padiatr"},{"key":"1933_CR5","unstructured":"Bundes\u00e4rztekammer (2003) Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Deutscher \u00c4rzte Verlag, K\u00f6ln"},{"key":"1933_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-139-1-200307010-00007","volume":"139","author":"Cordonnier","year":"2003","unstructured":"Cordonnier C, Chevret S, Legrand M et al. (2003) Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 139: 8\u201318","journal-title":"Ann Intern Med"},{"key":"1933_CR7","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al. (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329: 1993\u20132000","journal-title":"N Engl J Med"},{"key":"1933_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"Darenberg","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sjolin J et al. (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37: 333\u2013340","journal-title":"Clin Infect Dis"},{"key":"1933_CR9","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.55.9.1256","volume":"55","author":"Federico","year":"2000","unstructured":"Federico P, Zochodne DW, Hahn AF et al. (2000) Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 55: 1256\u20131262","journal-title":"Neurology"},{"key":"1933_CR10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM198205273062102","volume":"306","author":"Fehr","year":"1982","unstructured":"Fehr J, Hofmann V, Kappeler U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 306: 1254\u20131258","journal-title":"N Engl J Med"},{"key":"1933_CR11","doi-asserted-by":"crossref","unstructured":"Gadola S, Salzer U, Schultz H, Grimbacher B (2004) Adult manifestierende prim\u00e4re Immundefizienzen. Internist (Berl) 45: 912\u2013922","DOI":"10.1007\/s00108-004-1230-7"},{"key":"1933_CR12","first-page":"8","volume":"76","author":"Garbett","year":"1989","unstructured":"Garbett ND, Munro CS, Cole PJ (1989) Opsonic activity of a new intravenous immunoglobulin preparation: pentaglobin compared with sandoglobulin. Clin Exp Immunol 76: 8\u201312","journal-title":"Clin Exp Immunol"},{"key":"1933_CR13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ncpneuro0376","volume":"3","author":"Gold","year":"2007","unstructured":"Gold R, Stangel M, Dalakas MC (2007) Drug insight: the use of intravenous immunoglobulin in neurology \u2013 therapeutic considerations and practical issues. Nat Clin Pract Neurol 3: 36\u201344","journal-title":"Nat Clin Pract Neurol"},{"key":"1933_CR14","doi-asserted-by":"crossref","unstructured":"Gray O, McDonnell GV, Forbes RB (2003) Intravenous immunoglobulins for multiple sclerosis. Cochrane Database Syst Rev CD002936","DOI":"10.1002\/14651858.CD002936"},{"key":"1933_CR15","first-page":"499","volume":"13","author":"Guglielmo","year":"1994","unstructured":"Guglielmo BJ, Wong-Beringer A, Linker CA (1994) Immune globulin therapy in allogeneic bone marrow transplant: a critical review. Bone Marrow Transplant 13: 499\u2013510","journal-title":"Bone Marrow Transplant"},{"key":"1933_CR16","doi-asserted-by":"crossref","unstructured":"Hallek M, Eichhorst B, Dreger P (2006) Chronische lymphatische Leuk\u00e4mie. Leitlinien: Empfehlungen der DGHO f\u00fcr die Diagnostik und Therapie, Online-Publikation: http:\/\/www.dgho.de\/_cmsdata\/_file\/file_178.pdf","DOI":"10.1007\/s00761-006-1098-3"},{"key":"1933_CR17","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1055\/s-2003-41098","volume":"128","author":"Heiken","year":"2003","unstructured":"Heiken H, Schmidt RE (2003) Indikationen f\u00fcr den Einsatz von Immunglobulinen. Dtsch Med Wochenschr 128: 1665\u20131669","journal-title":"Dtsch Med Wochenschr"},{"key":"1933_CR18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.CCM.0000215452.84291.C6","volume":"34","author":"Hentrich","year":"2006","unstructured":"Hentrich M, Fehnle K, Ostermann H et al. (2006) IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial. Crit Care Med 34: 1319\u20131325","journal-title":"Crit Care Med"},{"key":"1933_CR19","unstructured":"Hiller E, Matzdorff A, Fischer JT (2005) Thrombozytopenien. Leitlinien: Empfehlungen der DGHO f\u00fcr die Diagnostik und Therapie, Online-Publikation: http:\/\/www.dgho.de\/_cmsdata\/_file\/file_129.pdf"},{"key":"1933_CR20","doi-asserted-by":"crossref","unstructured":"Hughes RA, Raphael JC, Swan AV, van Doorn PA (2006) Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev CD002063","DOI":"10.1002\/14651858.CD002063.pub3"},{"key":"1933_CR21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","volume":"28","author":"Kaul","year":"1999","unstructured":"Kaul R, McGeer A, Norrby-Teglund A et al. (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome \u2013 a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 28: 800\u2013807","journal-title":"Clin Infect Dis"},{"key":"1933_CR22","doi-asserted-by":"crossref","unstructured":"Ferencik M, Rovensky J, Matha V, Jensen-Jarolim E (2005) W\u00f6rterbuch Allergologie und Immunologie. Springer, Wien NewYork","DOI":"10.1007\/b138722"},{"key":"1933_CR23","doi-asserted-by":"crossref","unstructured":"Kreymann KG, de Heer G, Nierhaus A, Kluge S (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med (in press)","DOI":"10.1097\/00003246-200712000-00001"},{"key":"1933_CR24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/124.1.145","volume":"124","author":"Leger","year":"2001","unstructured":"Leger JM, Chassande B, Musset L et al. (2001) Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain 124: 145\u2013153","journal-title":"Brain"},{"key":"1933_CR25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","volume":"68","author":"Lyell","year":"1956","unstructured":"Lyell A (1956) Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 68: 355\u2013361","journal-title":"Br J Dermatol"},{"key":"1933_CR26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1086\/514588","volume":"26","author":"Norrby-Teglund","year":"1998","unstructured":"Norrby-Teglund A, Basma H, Andersson J et al. (1998) Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. Clin Infect Dis 26: 631\u2013638","journal-title":"Clin Infect Dis"},{"key":"1933_CR27","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.156.8.3057","volume":"156","author":"Norrby-Teglund","year":"1996","unstructured":"Norrby-Teglund A, Kaul R, Low DE et al. (1996) Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol 156: 3057\u20133064","journal-title":"J Immunol"},{"key":"1933_CR28","doi-asserted-by":"crossref","unstructured":"Oates-Whitehead RM, Baumer JH, Haines L et al. (2003) Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev CD004000","DOI":"10.1002\/14651858.CD004000"},{"key":"1933_CR29","first-page":"325","volume":"Med","author":"Oesser","year":"1999","unstructured":"Oesser S, Schulze C, Seifert J (1999) Protective capacity of a IgM\/IgA-enriched polyclonal immunoglobulin-G preparation in endotoxemia. Res Exp Med (Berl) 198: 325\u2013339","journal-title":"Res Exp"},{"key":"1933_CR30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1086\/421089","volume":"39","author":"Pildal","year":"2004","unstructured":"Pildal J, Gotzsche PC (2004) Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis 39: 38\u201346","journal-title":"Clin Infect Dis"},{"key":"1933_CR31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood.V93.3.942","volume":"93","author":"Rieben","year":"1999","unstructured":"Rieben R, Roos A, Muizert Y et al. (1999) Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 93: 942\u2013951","journal-title":"Blood"},{"key":"1933_CR32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00003246-199109000-00003","volume":"19","author":"Schedel","year":"1991","unstructured":"Schedel I, Dreikhausen U, Nentwig B et al. (1991) Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit Care Med 19: 1104\u20131113","journal-title":"Crit Care Med"},{"key":"1933_CR33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00105-006-1104-0","volume":"57","author":"Spornraft-Ragaller","year":"2006","unstructured":"Spornraft-Ragaller P, Theilen H, Gottschlich GS, Ragaller M (2006) Behandlung der toxischen epidermalen Nekrolyse. Erfahrungen bei 9\u00a0Patienten unter Ber\u00fccksichtigung von intraven\u00f6sen Immunglobulinen. Hautarzt 57: 185\u2013190, 192","journal-title":"Hautarzt"},{"key":"1933_CR34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00115-004-1733-4","volume":"75","author":"Stangel","year":"2004","unstructured":"Stangel M, Gold R (2004) Einsatz von i.v. Immunglobulinen in der Neurologie. Ein evidenzbasierter Konsens. Nervenarzt 75: 801\u2013815","journal-title":"Nervenarzt"},{"key":"1933_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2249.1998.00445.x","volume":"111","author":"Trautmann","year":"1998","unstructured":"Trautmann M, Held TK, Susa M et al. (1998) Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin Exp Immunol 111: 81\u201390","journal-title":"Clin Exp Immunol"},{"key":"1933_CR36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jnnp.59.3.248","volume":"59","author":"Van","year":"1995","unstructured":"Van den Berg LH, Kerkhoff H, Oey PL et al. (1995) Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 59: 248\u2013252","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1933_CR37","doi-asserted-by":"crossref","unstructured":"Werdan K (2005) Pr\u00e4vention und Therapie mit Immunglobulinen \u2013 Gesichertes und weniger Gesichertes. In: Werdan K, Schuster HP, M\u00fcller-Werdan U (Hrsg) Sepsis und MODS. Springer, Berlin Heidelberg New York Tokyo","DOI":"10.1007\/3-540-26587-2_9"},{"key":"1933_CR38","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/01.CCM.0000216189.80613.BB","volume":"34","author":"Werdan","year":"2006","unstructured":"Werdan K (2006) Immunoglobulin treatment in sepsis \u2013 is the answer \u201eno\u201c? Crit Care Med 34: 1542\u20131544","journal-title":"Crit Care Med"},{"key":"1933_CR39","doi-asserted-by":"crossref","unstructured":"Werdan K, Pilz G, the SBITS Study Group (1997) Polyvalent immune globulins. Shock 7 (Suppl): A5: 1918","DOI":"10.1097\/00024382-199703001-00020"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1933-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-007-1933-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1933-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T07:45:49Z","timestamp":1684050349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-007-1933-7"}},"subtitle":["Einsatz auch bei Sepsis und anderen Indikationen?","Should they also be used in sepsis and other indications?"],"short-title":[],"issued":{"date-parts":[[2007,9,29]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["1933"],"URL":"https:\/\/doi.org\/10.1007\/s00108-007-1933-7","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,29]]}}}